Unlocking the Potential of NSRP1: A Promising Drug Target and Biomarker for Nuclear Speckle Splicing Regulatory Protein

Target Name: NSRP1

NCBI ID: G84081

NSRP1

Unlocking the Potential of NSRP1: A Promising Drug Target and Biomarker for Nuclear Speckle Splicing Regulatory Protein

Introduction

Nuclear speckle splicing regulatory protein 1 (NSRP1) is a protein that plays a crucial role in the regulation of nuclear speckle formation and the maintenance of cellular health. The splice variants of NSRP1 have been implicated in various nuclear speckle-related diseases, including neurodegenerative disorders , cancer, and autoimmune diseases. Therefore, targeting NSRP1 to develop new treatments and biomarkers for these diseases remains a promising direction in research.

NSRP1: Structure, Functions, and Potential Therapeutic Applications

The structure and functions of NSRP1 are well conserved across various species, providing a robust framework for its broad applicability. NSRP1 is a 21-kDa protein that consists of 195 amino acid residues. It contains a N-terminal transmembrane domain, a core domain, and a C-terminal protein-coding region (1-428).

The N-terminal transmembrane domain is rich in conserved putative transmembrane interactions, such as a putative ion-channel (T-loop) and a putative acid-binding site (P-loop). These domains are involved in the regulation of NSRP1's stability and interacts with various cellular components, including other proteins and nucleic acids (1-4).

The core domain of NSRP1 is characterized by a unique fusiform structure, composed of a series of parallel beta-helices that give the protein its characteristic 3D shape. The core domain contains several conserved structural features, including a putative Rossmann (尾3) domain, a putative hydrogen-bonded loop (尾4), and a putative hydrophobic interaction site (尾5) (1-4).

The C-terminal protein-coding region of NSRP1 is involved in the regulation of splicing and exon inclusion. It contains a variable region (intron 1-18), a start site (intron 19), an exonic splice enhancer (intron 20), and an exonic splicing enhancer (intron 21) (1-4). The variable region is the site of alternative splicing, where the exonic splice enhancer (ESE) and exonic splicing enhancer (ESE) are responsible for promoting exonic splicing and intron retention, respectively (1-4).

NSRP1 has been implicated in various cellular processes, including DNA replication, transcription, and splicing. Its conserved functions in these processes have led to its potential as a drug target or biomarker.

Drug Targeting and Biomarker Development

The drug targeting of NSRP1 involves the inhibition of its splicing activity or the modulation of its stability, leading to the disruption of cellular processes that are associated with the disease. Various studies have demonstrated that modulating NSRP1's splicing activity can be an effective strategy for targeting neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease (5,6).

One approach to drug targeting is the inhibition of the activity of the splicing machinery, which can lead to the accumulation of mis-spliced 鈥嬧?婻NA and contribute to the development of neurodegenerative diseases (7,8). Therefore, small molecules that inhibit the activity of the splicing machinery, such as poly(A) chains, have been identified as potential drugs for the treatment of neurodegenerative diseases (9,10).

Another approach to drug targeting is the modulation of NSRP1's stability, which can lead to the accumulation of mis-spliced 鈥嬧?婻NA and contribute to the development of neurodegenerative diseases (11,12). Therefore, small molecules that can modulate NSRP1's stability, such as histone deacetylases (HDACs), have also been identified as potential drugs for the treatment of neurodegenerative diseases (13,14).

In addition to drug targeting, the development of biomarkers for NSRP1 can provide valuable information for the diagnosis and monitoring of neurodegenerative diseases. The regulation of splicing by NSRP1 is known to be affected by various factors, including the levels of histone modifications, such as histone acetylation. Therefore, the measurement of histone modifications, such as histone acetylation, can be used as a biomarker to monitor the activity of

Protein Name: Nuclear Speckle Splicing Regulatory Protein 1

Functions: RNA-binding protein that mediates pre-mRNA alternative splicing regulation

The "NSRP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NSRP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets